Viewing Study NCT01939418


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-06-09 @ 7:33 AM
Study NCT ID: NCT01939418
Status: TERMINATED
Last Update Posted: 2017-10-03
First Post: 2013-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
Sponsor: National Cancer Center, Korea
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic breast cancer View
None triple negative breast cancer View
None gemcitabine View
None RAD001 View